Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
it is a process that unfolds over weeks to months
In a May appearance on Breckas podcast, Kennedy again promised to end the war at FDA on peptides, stem cells, psychedelics and other fringe therapies
Statins for Graves orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial
Nally 8,975 views 11 citations Perspective 04 October 2024 A novel class of oral, non-immunosuppressive, beta cell-targeting, TXNIP-inhibiting T1D drugs is emerging Gu Jing , 1 more and Anath Shalev 7,830 views 11 citations Original Research 30 August 2024 Engineered IRES-mediated promoter-free insulin-producing cells reverse hyperglycemia Yumin Li , 8 more and Bo Sun 5,189 views 3 citations Original Research 01 August 2024 Abnormal late postprandial glucagon response in type 1 diabetes is a function of differences in stimulated C-peptide concentrations Lingyu Zhang , 5 more and Mei Zhang 4,042 views 8 citations Original Research 09 July 2024 Prediction of personalised postprandial glycaemic response in type 1 diabetes mellitus Xin Xiong , 3 more and Heng Su 4,865 views 8 citations Original Research 09 February 2024 Preserved C-peptide is common and associated with higher time in range in Chinese type 1 diabetes Wei Liu , 11 more and Linong Ji 3,940 views 1 citations Original Research 08 February 2024 Advances in risk predictive performance of pre-symptomatic type 1 diabetes via the multiplex Antibody-Detection-by-Agglutination-PCR assay Devangkumar Tandel , 4 more and Cheng-ting Tsai 4,311 views 4 citations Loading
US$ 27.22
US$ 27.92
US$ 27.98
US$ 23.54
US$ 20.97